Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Commending the investigators from AIIMS on the BBV152 study published in Lancet Infectious Diseases, Bharat…

View More Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld
WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld

WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld

The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech…

View More WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld
WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld

WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld

The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech…

View More WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld
We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld

We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld

NEW DELHI: Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said…

View More We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld
‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld

‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld

United Nations/Geneva: The World Health Organisation on Monday said it was expecting additional information from…

View More ‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld
Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets – ET HealthWorld

Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets – ET HealthWorld

MUMBAI: Homegrown Covaxin was to play a major role in vaccination against Covid-19. But eight…

View More Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets – ET HealthWorld
IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica – ET HealthWorld

IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica – ET HealthWorld

The International Vaccine Institute (IVI) today announced that the first participant received Bharat Biotech’s chikungunya…

View More IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica – ET HealthWorld
I never saw any report which said numbers will go very high: Biotech Secy – ET HealthWorld

I never saw any report which said numbers will go very high: Biotech Secy – ET HealthWorld

Department of Biotechnology secretary Renu Swarup speaks to ET on the virus variants at work,…

View More I never saw any report which said numbers will go very high: Biotech Secy – ET HealthWorld
Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum – ET HealthWorld

Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum – ET HealthWorld

To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up…

View More Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum – ET HealthWorld
Covid-19 vaccine: Virchow Biotech to make 200 million doses of Russia’s Sputnik V in India – ET HealthWorld

Covid-19 vaccine: Virchow Biotech to make 200 million doses of Russia’s Sputnik V in India – ET HealthWorld

MOSCOW: Russia‘s RDIF sovereign wealth fund said on Monday it had reached an agreement with…

View More Covid-19 vaccine: Virchow Biotech to make 200 million doses of Russia’s Sputnik V in India – ET HealthWorld
HC asks Serum Institute, Bharat Biotech to disclose Covid vaccines manufacturing capacity – ET HealthWorld

HC asks Serum Institute, Bharat Biotech to disclose Covid vaccines manufacturing capacity – ET HealthWorld

The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose…

View More HC asks Serum Institute, Bharat Biotech to disclose Covid vaccines manufacturing capacity – ET HealthWorld
Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm – ET HealthWorld

Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm – ET HealthWorld

NEW DELHI: A Chinese state-backed hacking group has in recent weeks targeted the IT systems…

View More Chinese hackers target Indian vaccine makers Serum Institute, Bharat Biotech: Security firm – ET HealthWorld